• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 COVID-19 大流行期间,胃肠病医生需要了解的事项。

What GI Physicians Need to Know During COVID-19 Pandemic.

机构信息

Institute of Digestive Health and Liver Diseases, Mercy Medical Center, Baltimore, MD, USA.

Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

出版信息

Dig Dis Sci. 2021 Sep;66(9):2865-2875. doi: 10.1007/s10620-020-06625-4. Epub 2020 Oct 5.

DOI:10.1007/s10620-020-06625-4
PMID:33015748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7533169/
Abstract

The worldwide pandemic of COVID-19, caused by the virus SARS-CoV-2, continues to cause significant morbidity and mortality in both low- and high-income countries. Although COVID-19 is predominantly a respiratory illness, other systems including gastrointestinal (GI) system and liver may be involved because of the ubiquitous nature of ACE-2 receptors in various cell lines that SARS-CoV-2 utilizes to enter host cells. It appears that GI symptoms and liver enzyme abnormalities are common in COVID-19. The involvement of the GI tract and liver correlates with the severity of disease. A minority (10-20%) of patients with COVID-19 may also present initially with only GI complaints. The most common GI symptoms are anorexia, loss of smell, nausea, vomiting, and diarrhea. Viral RNA can be detected in stool in up to 50% of patients, sometimes even after pharyngeal clearance, but it is unclear whether fecal-oral transmission occurs. Liver enzymes are elevated, usually mild (2-3 times), in a substantial proportion of patients. There are many confounding factors that could cause liver enzyme abnormalities including medications, sepsis, and hypoxia. Although infection rates in those with preexisting liver disease are similar to that of general population, once infected, patients with liver disease are more likely to have a more severe disease and a higher mortality. There is a paucity of objective data on the optimal preventive or management strategies, but few recommendations for GI physicians based on circumstantial evidence are discussed.

摘要

由病毒 SARS-CoV-2 引起的 COVID-19 全球大流行继续在低收入和高收入国家造成重大发病率和死亡率。尽管 COVID-19 主要是一种呼吸道疾病,但由于 ACE-2 受体在 SARS-CoV-2 用于进入宿主细胞的各种细胞系中普遍存在,其他系统(包括胃肠道[GI]系统和肝脏)也可能受到影响。似乎 COVID-19 常见胃肠道症状和肝酶异常。胃肠道受累和肝脏与疾病的严重程度相关。少数(10-20%)COVID-19 患者最初可能仅出现胃肠道症状。最常见的胃肠道症状是食欲不振、嗅觉丧失、恶心、呕吐和腹泻。多达 50%的患者粪便中可检测到病毒 RNA,有时甚至在清除咽部后也是如此,但尚不清楚是否发生粪-口传播。相当一部分患者的肝酶升高,通常为轻度(2-3 倍)。许多混杂因素可导致肝酶异常,包括药物、败血症和缺氧。尽管患有慢性肝病的患者的感染率与一般人群相似,但一旦感染,肝病患者更有可能出现更严重的疾病和更高的死亡率。关于最佳预防或管理策略的客观数据很少,但根据间接证据,我们讨论了一些针对胃肠病医生的建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138f/7533169/d5ebf1e33aa1/10620_2020_6625_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138f/7533169/d5ebf1e33aa1/10620_2020_6625_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/138f/7533169/d5ebf1e33aa1/10620_2020_6625_Fig1_HTML.jpg

相似文献

1
What GI Physicians Need to Know During COVID-19 Pandemic.在 COVID-19 大流行期间,胃肠病医生需要了解的事项。
Dig Dis Sci. 2021 Sep;66(9):2865-2875. doi: 10.1007/s10620-020-06625-4. Epub 2020 Oct 5.
2
COVID-19 extrapulmonary illness - special gastrointestinal and hepatic considerations.COVID-19 肺外疾病——特殊的胃肠道和肝脏注意事项。
Dis Mon. 2020 Sep;66(9):101064. doi: 10.1016/j.disamonth.2020.101064. Epub 2020 Jul 28.
3
COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.COVID-19 大流行:胃肠道的病理生理学和表现。
World J Gastroenterol. 2020 Aug 21;26(31):4579-4588. doi: 10.3748/wjg.v26.i31.4579.
4
Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings.目前对 COVID-19 对胃肠道疾病影响的认识:挑战与机遇。
World J Gastroenterol. 2021 Feb 14;27(6):449-469. doi: 10.3748/wjg.v27.i6.449.
5
Gastrointestinal Manifestations and Their Association with Neurologic and Sleep Problems in Long COVID-19 Minority Patients: A Prospective Follow-Up Study.长新冠少数民族患者的胃肠道症状及其与神经系统和睡眠问题的关联:一项前瞻性随访研究。
Dig Dis Sci. 2024 Feb;69(2):562-569. doi: 10.1007/s10620-023-08176-w. Epub 2023 Dec 22.
6
COVID-19 induces gastrointestinal symptoms and affects patients' prognosis.新冠病毒可引起胃肠道症状,并影响患者的预后。
J Int Med Res. 2022 Oct;50(10):3000605221129543. doi: 10.1177/03000605221129543.
7
Gastrointestinal implications in COVID-19.新型冠状病毒肺炎的胃肠道影响。
J Investig Med. 2020 Dec;68(8):1397-1401. doi: 10.1136/jim-2020-001559. Epub 2020 Sep 14.
8
Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review.新型冠状病毒肺炎的胃肠道和肝脏表现:全面综述。
World J Gastroenterol. 2020 May 21;26(19):2323-2332. doi: 10.3748/wjg.v26.i19.2323.
9
Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.宿主对 SARS-CoV2 及现有肝脏和胃肠道疾病中新兴变异株的反应。
Front Cell Infect Microbiol. 2021 Oct 25;11:753249. doi: 10.3389/fcimb.2021.753249. eCollection 2021.
10
Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis.新型冠状病毒肺炎患者的胃肠及肝脏表现、各国患病率、病死率和重症监护病房入住率:系统评价和荟萃分析。
BMJ Open Gastroenterol. 2021 Mar;8(1). doi: 10.1136/bmjgast-2020-000571.

引用本文的文献

1
The COVID-19 Patient in the Surgical Intensive Care Unit.《外科重症监护病房的 COVID-19 患者》
Surg Clin North Am. 2022 Feb;102(1):1-21. doi: 10.1016/j.suc.2021.09.015. Epub 2021 Sep 29.
2
Insights into the management of anorectal disease in the coronavirus 2019 disease era.2019年冠状病毒病时代肛管直肠疾病管理的见解
Therap Adv Gastroenterol. 2021 Jul 9;14:17562848211028117. doi: 10.1177/17562848211028117. eCollection 2021.
3
Ampullitis Superimposed Obstructive Jaundice in a Patient With COVID-19.一名新冠肺炎患者合并壶腹炎叠加梗阻性黄疸

本文引用的文献

1
Risk factors for acute stroke-associated pneumonia and prediction of neutrophil-to-lymphocyte ratios.急性脑卒中相关性肺炎的危险因素及中性粒细胞与淋巴细胞比值的预测。
Am J Emerg Med. 2021 Mar;41:55-59. doi: 10.1016/j.ajem.2020.12.036. Epub 2020 Dec 23.
2
Gut Microbial Metagenomics in ACLF: The Causality-Association Conundrum.急性肝衰竭中的肠道微生物宏基因组学:因果关系关联难题
Gastroenterology. 2021 May;160(6):2205. doi: 10.1053/j.gastro.2020.12.055. Epub 2020 Dec 30.
3
Predictive Role of Tumor Budding in T1 Colorectal Cancer Lymph Node Metastasis.
Gastroenterology Res. 2021 Feb;14(1):41-44. doi: 10.14740/gr1353. Epub 2021 Feb 19.
肿瘤芽生在T1期结直肠癌淋巴结转移中的预测作用
Gastroenterology. 2021 Aug;161(2):732-733. doi: 10.1053/j.gastro.2020.12.053. Epub 2020 Dec 30.
4
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.巴瑞替尼联合瑞德西韦治疗住院的新冠成年患者
N Engl J Med. 2021 Mar 4;384(9):795-807. doi: 10.1056/NEJMoa2031994. Epub 2020 Dec 11.
5
Dynamics and Correlation Among Viral Positivity, Seroconversion, and Disease Severity in COVID-19 : A Retrospective Study.新冠病毒阳性、血清转换和疾病严重程度之间的动态关系:一项回顾性研究。
Ann Intern Med. 2021 Apr;174(4):453-461. doi: 10.7326/M20-3337. Epub 2020 Dec 8.
6
Screening is associated with a lower risk of hepatocellular carcinoma-related mortality in patients with chronic hepatitis B.筛查可降低慢性乙型肝炎患者肝细胞癌相关死亡率。
J Hepatol. 2021 Apr;74(4):850-859. doi: 10.1016/j.jhep.2020.11.023. Epub 2020 Nov 24.
7
Targeting Nestin hepatic stellate cells ameliorates liver fibrosis by facilitating TβRI degradation.靶向巢蛋白肝星状细胞通过促进 TβRI 降解来改善肝纤维化。
J Hepatol. 2021 May;74(5):1176-1187. doi: 10.1016/j.jhep.2020.11.016. Epub 2020 Nov 17.
8
Engineering a Mobile Platform to Promote Sleep in the Pediatric Primary Care Setting.打造一个移动平台以促进儿科初级保健环境中的睡眠。
medRxiv. 2020 Nov 7:2020.11.06.20223719. doi: 10.1101/2020.11.06.20223719.
9
Racial Disproportionality in Covid Clinical Trials.新冠临床试验中的种族不均衡现象。
N Engl J Med. 2020 Dec 17;383(25):2486-2487. doi: 10.1056/NEJMc2029374. Epub 2020 Nov 6.
10
Reply.回复。
Gastroenterology. 2021 Mar;160(4):1430-1431. doi: 10.1053/j.gastro.2020.10.014. Epub 2020 Oct 14.